主动脉瓣狭窄的主动管理与治疗:国际专家视角
2025年ESC/EACTS指南挑战症状驱动的观察等待策略,支持对无症状重度主动脉瓣狭窄患者早期治疗。该国际专家视角提出主动管理策略与操作框架,包括早期转诊心脏瓣膜团队、简化评估、上游检测、及时置换及结构化监测,以改善时效性、效率与公平性,减少可预防的发病和死亡。
要点
- 无症状重度主动脉瓣狭窄不再一律观察等待,多患者可早期干预。
- 早期转诊心脏瓣膜团队并简化评估是主动管理的核心环节。
- 延迟干预者需结构化监测,转诊医生与瓣膜团队紧密协作。
核心结论
- 支持对许多无症状重度主动脉瓣狭窄患者早期治疗,倡导主动管理策略以改善长期结局。
研究设计与样本
- 国际专家视角文章,基于2025年ESC/EACTS指南提出主动管理策略与操作框架。
主要发现
- 关键要素包括早期转诊心脏瓣膜团队、简化评估、上游检测、及时主动脉瓣置换及结构化监测。
关键数值与推荐
- 对许多无症状重度主动脉瓣狭窄患者及时行主动脉瓣置换,对有症状患者更紧急治疗。
临床怎么用
- 临床应早期转诊心脏瓣膜团队,简化评估流程,对延迟干预者实施结构化监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 2025 European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines mark a pivotal change, challenging the paradigm of symptom-driven watchful waiting, and supporting earlier treatment in many patients with asymptomatic severe aortic stenosis. Building on this foundation, this international expert perspective advocates a comprehensive, proactive management strategy and offers clinicians a contemporary operational framework for managing severe aortic stenosis. Key evidence-based elements include early referral to the multidisciplinary Heart Valve Team, streamlined evaluation, upstream testing, prompt aortic valve replacement in many asymptomatic patients, more urgent treatment for symptomatic patients, and structured surveillance involving close working relationships between the referring clinician and Heart Valve Team when intervention is deferred. This proactive evidence-based model aims to improve timeliness, efficiency, and equity of care, thereby reducing preventable morbidity and mortality and improving long-term outcomes.
引用
- Cook CM, Pibarot P, Tarantini G, et al. Proactive Management and Treatment of Aortic Stenosis: An International Expert Perspective. J Am Coll Cardiol. 2025. PMID: 41636408. doi:10.1016/j.jacc.2025.10.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。